MicroRNA expression profile in endometriosis: Its relation to angiogenesis and fibrinolytic factors

Human Reproduction

Volumn 29, Issue 5, 2014, Pages 978-988

  Braza Boïls, Aitana ^a   Marí Alexandre, Josep ^a   Gilabert, Juan ^b   Sánchez Izquierdo, Dolors ^a   España, Francisco ^c   Estellés, Amparo ^c   Gilabert Estellés, Juan ^d  

^a INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

angiogenesis; endometriosis; fibrinolysis; microRNA; VEGF A

Indexed keywords

FIBRINOLYTIC FACTOR; MICRORNA; MICRORNA 202 3P; MICRORNA 424 5P; MICRORNA 449B 3P; MICRORNA 556 3P; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; UROKINASE; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ARTICLE; CASE CONTROL STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; OVARIAN ENDOMETRIOMA; OVARY TUMOR; PATHOGENESIS; PERITONEUM; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENETICS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; MICRORNAS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOSPONDIN 1; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84898919547     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu019     Document Type: Article

References (58)

1. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-355.
2. Balasch J, Creus M, Fábregues F, Carmona F, Ordi J, Martinez-Román S, Vanrell JA. Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study. Hum Reprod 1996;11:387-391.
3. Bartel DP. Micro RNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
4. Bartel DP. Micro RNAs: target recognition and regulatory functions. Cell 2009;136:215-233.
5. Bouchet-Bernet C, Spyratos F, Andrieu C, Deytieux S, Becette V, Oglobine J. Influenceofthe extraction procedureon plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues. Breast Cancer Res Treat 1996;41:141-146.
6. Braza-Böils A, Gilabert-Estellés J, Ramón LA, Gilabert J, Maŕi-Alexandre J, Chirivella M, España F, Estellés A. Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis. PLoS ONE 2013; 8:e62370.
7. Bulun SE. Endometriosis. N Engl J Med 2009;360:268-279.
8. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012;98:511-519.
9. Burney RO, Hamilton AE, Aghajanova L, Vo KC, Nezhat CN, Lessey BA, Giudice LC. Micro RNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis. Mol Hum Reprod 2009;15:625-631.
10. Cao X, Geradts J, Dewhirst MW, Lo HW. Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene 2012; 31:104-115.
11. Carpenter RL, Lo HW. Hedgehog pathway and GLI1 isoforms in human cancer. Discov Med 2012;13:105-113.
12. Chakrabarti M, Banik NL, Ray SK. miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo. Exp Cell Res 2013; 319:1575-1585.
13. Chamorro-Jorganes A, Araldi E, Penalva LO, Sandhu D, Fernández- Hernando C, Suárez Y. Micro RNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol 2011;31:2595-2606.
14. Chung TK, Lau TS, Cheung TH, Yim SF, Lo KW, Siu NS, Chan LK, Yu MY, Kwong J, Doran G et al. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int. J. Cancer 2012;130:1036-1045.
15. Cośin R, Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Romeu A, Estellés A. Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression. Fertil Steril 2009; 92:1214-1220.
16. Cośin R, Gilabert-Estellés J, Ramón LA, Gómez-Lechón MJ, Gilabert J, Chirivella M, Braza-Böils A, España F, Estellés A. Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis. Hum Reprod 2010;25:398-405.
17. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998; 13:1686-1690.
18. Filigheddu N, Gregnanin I, Porporato PE, Surico D, Perego B, Galli L, Patrignani C, Graziani A, Surico N. Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotechnol 2010;2010:369549.
19. Gilabert-Estellés J, Estellés A, Gilabert J, Castelló R, España F, Falcó C, Romeu A, Chirivella M, Zorio E, Aznar J. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod 2003;18:1516-1522.
20. Gilabert-Estellés J, Castelló R, Gilabert J, Ramón LA, España F, Romeu A, Estellés A. Plasminogen activators and plasminogen activator inhibitors in endometriosis. In 'Tissue Remodeling Factors in the Physiology and Pathophysiology of the Female Reproductive Tract'. Front Biosc 2005; 10:1162-1176.
21. Gilabert-Estelles J, Ramon LA, España F, Gilabert J, Castello R, Estelles A. Expression of the fibrinolytic components in endometriosis. Pathophysiol Haemost Thromb. 2006;35:136-140.
22. Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Vila V, Réganon E, Castelló R, Chirivella M, Estellés A. Expression of angiogenic factors in endometriosis: its relation to fibrinolytic and metalloproteinase (MMP) systems. Hum Reprod 2007;22:2120-2127.
23. Gilabert-Estelles J, Braza-Boils A, Ramon LA, Zorio E, Medina P, Espana F, Estelles A. Role of microRNAs in gynecological pathology. Curr Med Chem 2012;19:2406-2413.
24. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-1799.
25. Guo SW. Epigenetics of endometriosis. Mol Hum Reprod 2009:15:587-607.
26. Hapangama DK, Raju RS, Valentijn AJ, Barraclough D, Hart A, Turner MA, Platt-Higgins A, Barraclough R, Rudland PS. Aberrant expression of metastasis-inducing proteins in ectopic and matched eutopic endometrium of women with endometriosis: implications for the pathogenesis of endometriosis. Hum Reprod 2012;27:394-407.
27. Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, Gunaratne PH, Matzuk MM. Functional microRNA involved in endometriosis. Mol Endocrinol 2011;25:821-832.
28. Ibberson D, Benes V, Muckenthaler MU, Castoldi M. RNA degradation compromises the reliability of microRNA expression profiling. BMC Biotechnol 2009;9:102.
29. Klemmt PA, Carver JG, Konincks P, Mc Veigh EJ, Mardon HJ. Endometrial cells from women with endometriosis have increased adhesion and proliferative capacity in response to extracellular matrix components: towards a mechanistic model for endometriosis progression. Hum Reprod 2007;22:3139-3147.
30. Kuokkanen S, Chen B, Ojalvo L, Benard L, Santoro N, Pollard JW. Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod 2010; 82:791-801.
31. Laschke MW, Menger MD. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update 2007;13:331-342.
32. Laudanski P, Charkiewicz R, Kuzmicki M, Szamatowicz J, Charkiewicz A, Niklinski J. Micro RNAs expression profiling of eutopic proliferative endo-metrium in women with ovarian endometriosis. Reprod Biol Endocrinol 2013;11:78.
33. Liu X, Wang C, Chen Z, Jin Y, Wang Y, Kolokythas A, Dai Y, Zhou X. Micro RNA-138 suppresses epithelial-mesenchymal transition in squa-mous cell carcinoma cell lines. Biochem J 2011;440:23-31.
34. Matsuzaki S, Darcha C. Epithelial to mesenchymal transition-like and mesenchymal to epithelial transition-like processes might be involved in the pathogenesisof pelvic endometriosis. Hum Reprod 2012;27:712-721.
35. Mc Kinnon B, Bersinger NA, Wotzkow C, Mueller MD. Endometriosis- associated nerve fibers, peritoneal fluid cytokine concentrations, and pain in endometriotic lesions from different locations. Fertil Steril 2012; 97:373-380.
36. Mc Laren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000;6:45-55.
37. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis and adenomyotic nodules of the rectovaginal septum are three different entities. Fert Steril 1997;68:585-596.
38. Nisolle M, Casanas-Roux F, Anaf V, Mine JM, Donnez J. Morphometric study of the stromal vascularizationinperitoneal endometriosis. Fertil Steril 1993; 59:681-684.
39. Ohlsson Teague E, Van der Hoek K, Van der Hoek M, Perry N, Wagaarachchi P, Robertson S, Print C, Hull L. Micro RNA-regulated pathways associated with endometriosis. Mol Endocrinol 2009;23:265-275.
40. Ohlsson-Teague EM, Print CG, Hull ML. The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update 2010;16:146-165.
41. Pan Q, Chegini N. Micro RNA signature and regulatory functions in the endometrium during normal and disease states. Semin Reprod Med 2008; 26:479-493.
42. Pan Q, Luo X, Toloubeydokhti T, Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007;13:797-806.
43. Qin B, Yang H, Xiao B. Role of microRNAs in endothelial inflammation and senescence. Mol Biol Rep 2012;39:4509-4518.
44. Qiu S, Huang D, Yin D, Li F, Li X, Kung HF, Peng Y. Suppression of tumorigenicity by Micro RNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme. Biochim Biophys Acta 2013;1832:1697-1707.
45. Ramón LA, Gilabert-Estellés J, Castelló R, Gilabert J, España F, Romeu A, Chirivella M, Aznar J, Estellés A. mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay. Hum Reprod 2005;20:272-278.
46. Ramón LA, Braza-Böils A, Gilabert-Estellés J, Gilabert J, España F, Chirivella M, Estellés A. microRNAs expression in endometriosis and their relation to angiogenic factors. Hum Reprod 2011;26:1082-1090.
47. Ramón LA, Braza-Böils A, Gilabert J, España F, Chirivella M, Estellés A, Gilabert-Estellés J. microRNAs related to angiogenesis are dysregulated in endometriod endometrial cancer. Human Reprod 2012;27:3036-3045.
48. Santoni M, Burattini L, Nabissi M, Morelli MB, Berardi R, Santoni G, Cascinu S. Essential role of Gli proteins in glioblastoma multiforme. Curr Protein Pept Sci 2013;14:133-140.
49. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jaffe RB, Taylor RN. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112-3118.
50. Sonkoly E, Pivarcsi A. microRNAs in inflammation. Int Rev Immunol 2009; 28:535-561.
51. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, Zhu L. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 2002;78:148-153.
52. Toloubeydokhti T, Pan Q, Luo X, Bukulmez O, Chegini N. The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod Sci 2008;15:993-1001.
53. Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008;79:581-588.
54. Wang S, Olson EN. Angiomi Rs: key regulators of angiogenesis. Curr Opin Genet Dev 2009;19:205-211.
55. Wang Q, Tang H, Yin S, Dong C. Downregulationofmicro RNA-138enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of Rho C/p-ERK/MMP-2/MMP-9. Oncol Rep 2013;29:2046-2052.
56. Young VJ, Brown JK, Saunders PT, Horne AW. The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update 2013; 19:558-569.
57. Zhao Y, Li C, Wang M, Su L, Qu Y, Li J, Yu B, Yan M, Yu Y, Liu B et al. Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer. PLoS ONE 2013;8:e69756.
58. Zorio E, Medina P, Rueda J, Millán JM, Arnau MA, Beneyto M, Maŕin F, Gimeno JR, Osca J, Salvador A et al. Insights of the role of microRNAs in cardiac diseases: from biological signaling to therapeutic targets. Cardiovas & Hematol Agent in Med Chem 2009;7:82-90.